Cellular senescence in cancer
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Cellular senescence, a process of cell proliferation arrest in response to various stressors, has been considered to be important factor in age-related disease. Identification of senescent cells in tissues is limited and the role of senescent cells is poorly understood. Recently however, several studies showed the characterization of senescent cells in various pathologic conditions and the role of senescent cells in disease progression is becoming important. Senescent cells are growth-arrested cells, however, the senescence associated secretory phenotype (SASP) of senescent cells could modify the tissues’ microenvironment. Here, we discuss the progress and understanding of the role of senescent cells in tissues of pathologic conditions and discuss the development of new therapeutic paradigms, such as senescent cells-targeted therapy.
Abstract
Cellular senescence, a process of cell proliferation arrest in response to various stressors, has been considered to be important factor in age-related disease. Identification of senescent cells in tissues is limited and the role of senescent cells is poorly understood. Recently however, several studies showed the characterization of senescent cells in various pathologic conditions and the role of senescent cells in disease progression is becoming important. Senescent cells are growth-arrested cells, however, the senescence associated secretory phenotype (SASP) of senescent cells could modify the tissues’ microenvironment. Here, we discuss the progress and understanding of the role of senescent cells in tissues of pathologic conditions and discuss the development of new therapeutic paradigms, such as senescent cells-targeted therapy.
참고문헌 (59)
- Hayflick L, "The serial cultivation of human diploid cell strains", Exp Cell Res, 25, pp.585~621 (1961)
- Herbert B, "Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death", Proc Natl Acad Sci U S A, 96, pp.14276~14281 (1999)
- Baird DM, "Extensive allelic variation and ultrashort telomeres in senescent human cells", Nat Genet, 33, pp.203~207 (2003)
- Baerlocher GM, "Telomere shortening in leukocyte subpopulations from baboons", J Leukoc Biol, 73, pp.289~296 (2003)
- Lopez-Otin C, "The hallmarks of aging", Cell, 153, pp.1194~1217 (2013)
- Kuilman T, "The essence of senescence", Genes Dev, 24, pp.2463~2479 (2010)
- Collado M, "Cellular senescence in cancer and aging", Cell, 130, pp.223~233 (2007)
- Campisi J, "Cellular senescence : when bad things happen to good cells", Nat Rev Mol Cell Biol, 8, pp.729~740 (2007)
- Storer M, "Senescence is a developmental mechanism that contributes to embryonic growth and patterning", Cell, 155, pp.1119~1130 (2013)
- Munoz-Espin D, "Programmed cell senescence during mammalian embryonic development", Cell, 155, pp.1104~1118 (2013)
- Baker DJ, "Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders", Nature, 479, pp.232~236 (2011)
- Martin JA, "Aging, articular cartilage chondrocyte senescence and osteoarthritis", Biogerontology, 3, pp.257~264 (2002)
- Minamino T, "Vascular cell senescence : contribution to atherosclerosis", Circ Res, 100, pp.15~26 (2007)
- Childs BG, "Cellular senescence in aging and age-related disease : from mechanisms to therapy", Nat Med, 21, pp.1424~1435 (2015)
- Bodnar AG, "Extension of life-span by introduction of telomerase into normal human cells", Science, 279, pp.349~352 (1998)
- Munoz-Espin D, "Cellular senescence : from physiology to pathology", Nat Rev Mol Cell Biol, 15, pp.482~496 (2014)
- Vicente R, "Cellular senescence impact on immune cell fate and function", Aging Cell, 15, pp.400~406 (2016)
- Tchkonia T, "Cellular senescence and the senescent secretory phenotype : therapeutic opportunities", J Clin Invest, 123, pp.966~972 (2013)
- Serrano M, "Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a", Cell, 88, pp.593~602 (1997)
- Chen Z, "Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis", Nature, 436, pp.725~730 (2005)
- Michaloglou C, "BRAFE600-associated senescence-like cell cycle arrest of human naevi", Nature, 436, pp.720~724 (2005)
- Althubiti M, "Characterization of novel markers of senescence and their prognostic potential in cancer", Cell Death Dis, 5, pp.e1528~ (2014)
- Collado M, "Tumour biology : senescence in premalignant tumours", Nature, 436, pp.642~ (2005)
- Krtolica A, "Senescent fibroblasts promote epithelial cell growth and tumorigenesis : a link between cancer and aging", Proc Natl Acad Sci U S A, 98, pp.12072~12077 (2001)
- Haugstetter AM, "Cellular senescence predicts treatment outcome in metastasised colorectal cancer", Br J Cancer, 103, pp.505~509 (2010)
- Reimann M, "Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence", Cancer Cell, 17, pp.262~272 (2010)
- Vizioli MG, "Evidence of oncogene-induced senescence in thyroid carcinogenesis", Endocr Relat Cancer, 18, pp.743~757 (2011)
- Kim YH, "Senescent tumor cells lead the collective invasion in thyroid cancer", Nat Commun, 8, pp.15208~ (2017)
- Denoyelle C, "Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway", Nat Cell Biol, 8, pp.1053~1063 (2006)
- Debacq-Chainiaux F, "Protocols to detect senescenceassociated beta-galactosidase(SA-betagal)activity, a biomarker of senescent cells in culture and in vivo", Nat Protoc, 4, pp.1798~1806 (2009)
- Dimri GP, "A biomarker that identifies senescent human cells in culture and in aging skin in vivo", Proc Natl Acad Sci U S A, 92, pp.9363~9367 (1995)
- Yoon JE, "Senescent fibroblasts drive ageing pigmentation : A potential therapeutic target for senile lentigo", Theranostics, 8, pp.4620~4632 (2018)
- Bennecke M, "Ink4a", Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis, 2010, pp.18, 135~146
- Ancrile B, "Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis", Genes Dev, 21, pp.1714~1719 (2007)
- Sparmann A, "Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis", Cancer Cell, 6, pp.447~458 (2004)
- el-Deiry WS, "WAF1", CIP1 is induced in p53-mediated G1 arrest and apoptosis, 1994, pp.54, 1169~1174
- Di Leonardo A, "DNA damage triggers a prolonged p53-dependent G1arrest and long-term induction of Cip1 in normal human fibroblasts", Genes Dev, 8, pp.2540~2551 (1994)
- Liu M, "UV-B", A irradiation of mouse keratinocytes results in p53-mediated WAF1, Oncogene, pp.1995, 10[DOI]
- Stein GH, "Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts", Mol Cell Biol, 19, pp.2109~2117 (1999)
- Lee CJ, "Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6", E7 gene expression in cells immortalized by HPV16 DNA, 2002, pp.277, 173~182
- Gabay C, "Interleukin-6 and chronic inflammation", Arthritis Res Ther, 8(Suppl 2), pp.S3~ (2006)
- Kunkel SL, "Interleukin-8(IL-8) : the major neutrophil chemotactic factor in the lung", Exp Lung Res, 17, pp.17~23 (1991)
- Coppe JP, "The senescence-associated secretory phenotype : the dark side of tumor suppression", Annu Rev Pathol, 5, pp.99~118 (2010)
- Freund A, "Inflammatory networks during cellular senescence : causes and consequences", Trends Mol Med, 16, pp.238~246 (2010)
- Liu D, "Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion", Cancer Res, 67, pp.3117~3126 (2007)
- Parrinello S, "Stromal-epithelial interactions in aging and cancer : senescent fibroblasts alter epithelial cell differentiation", J Cell Sci, 118, pp.485~496 (2005)
- Biran A, "Quantitative identification of senescent cells in aging and disease", Aging Cell, 16, pp.661~671 (2017)
- Jun JI, "The matricellular protein CCN1induces fibroblast senescence and restricts fibrosis in cutaneous wound healing", Nat Cell Biol, 12, pp.676~685 (2010)
- Krizhanovsky V, "Senescence of activated stellate cells limits liver fibrosis", Cell, 134, pp.657~667 (2008)
- Coppe JP, "Senescenceassociated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor", PLoS Biol, 6, pp.2853~2868 (2008)
- Kim YH, "TSH signaling overcomes B-RafV600E-induced senescence in papillary thyroid carcinogenesis through regulation of DUSP6", Neoplasia, 16, pp.1107~1120 (2014)
- Cisowski J, "Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF", Oncogene, 35, pp.1328~1333 (2016)
- Dankort D, "Braf(V600E)cooperates with Pten loss to induce metastatic melanoma", Nat Genet, 41, pp.544~552 (2009)
- Bos JL, "ras oncogenes in human cancer : a review", Cancer Res, 49, pp.4682~4689 (1989)
- Milde-Langosch K, "Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype", Breast Cancer Res Treat, 67, pp.61~70 (2001)
- Jaszewski R, "Aging and cancer of the stomach and colon", Front Biosci, 4, pp.D322~D328 (1999)
- Bleul CC, "The lymphocyte chemoattractant SDF-1 is a ligand for LESTR", fusin and blocks HIV-1 entry, 1996, pp.382, 829~833
- Ho IA, "Matrix metalloproteinase-1-mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1", C-X-C chemokine receptor 4 axis, 2014, pp.28, 4359~4368
- Chen JH, "Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts", J Biol Chem, 279, pp.49439~49446 (2004)
